BusinessOncoMed to Present Data at the American Association of Cancer Research Annual Meeting 2016By Nasdaq OMXMar 16, 2016, 8:30 PM UTC
BusinessOncoMed Presents Updated Phase 1b Data for Demcizumab in First-Line Pancreatic Cancer at the Gastrointestinal Cancers SymposiumBy Nasdaq OMXJan 22, 2016, 1:30 PM UTC
BusinessOncoMed Pharmaceuticals Appoints Perry Karsen to Board of DirectorsBy Nasdaq OMXJan 6, 2016, 1:30 PM UTC
